← Back to Patent Explorer
US5275838A Expired / Lapsed US ⏱️ 0.0 years remaining

Immobilized polyethylene oxide star molecules for bioapplications

Assignee: Massachusetts Institute of Technology
•
Filing: 1992-06-12
•
Granted: 1994-01-04
•
Expires: 2012-06-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for immobilizing polyethylene oxide (PEO) star molecules in the form of hydrogel layers and a product thereof are disclosed. The PEO star molecules are biocompatible and demonstrate non-thrombogenic properties. As such, the PEO star molecule layers have numerous biomedical applications, such as on contact lenses. The hydrogel layers contain a high percentage of terminal hydroxyl groups for attachment of affinity ligands and can be used for separating and purifying therapeutic proteins.

Inventors

  • 👤 Edward W. Merrill

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 13:03
CPC Classifications
B; B01; B01D; B01D67/00; B01D67/0081; B01D67/0093; B01D67/00933; A; A61; A61K; A61K47/00; A61K47/50; A61K47/69; A61K47/6903; A61K47/6957; A61L; A61L33/00; A61L33/0005; A61L33/0011; A61L33/0029; A61L33/0064; A61L33/06; A61L33/068; B01D67/0088; B01J; B01J20/00; B01J20/30; B01J20/32; B01J20/3202; B01J20/3206; B01J20/3208; B01J20/321; B01J20/3212; B01J20/3214; B01J20/3217; B01J20/3219; B01J20/3225; B01J20/3231; B01J20/3242; B01J20/3268; B01J20/3272; B01J20/328; B01J20/3282; C; C07; C07K; C07K1/00; C07K1/14; C07K1/16; C07K1/22; C08; C08G; C08G65/00; C08G65/02; C08G65/32; C08G65/329; C08G65/331; C08G65/332; C08G65/333; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/544; G01N33/545; G02; G02B; G02B1/00; G02B1/04; G02B1/041; G02B1/043; B01D2323/00; B01D2323/30; B01D2323/34; Y; Y10; Y10S; Y10S525/00; Y10S525/937

Claims Analysis

Total Claims: 24
Claim 1
Independent Claim 161 words
A method for immobilizing polyethylene oxide (PEO) star molecules to a support surface to form a layer thereon, comprising the steps of: a) exposing an organic solution, comprising polyethylene oxide star molecules each of which consists essentially of a plurality of hydroxy-terminated polyethylene oxide chains attached to a divinyl benzene core, to a reagent to affix reagent groups to the hydroxy termini, said reagent groups permitting subsequent attachment of amino or thiol groups to the PEO chain ends by displacement, thereby forming activated polyethylene oxide star molecules with active reagent end groups; b) separating the activated polyethylene oxide star molecules with active reagent end groups from the organic solvent; c) dissolving the activated polyethylene oxide star molecules in an aqueous solution; and d) contacting the solution of step (c) with a support surface containing amino and/or thiol groups to covalently bind the reagent terminated star molecules, thereby immobilizing the reagent terminated star molecules in a dense layer to the support surface.
Claim 2
Independent Claim 161 words
A method for immobilizing polyethylene oxide (PEO) star molecules to a support surface to form a layer thereon, comprising the steps of: a) exposing an organic solution, comprising polyethylene oxide star molecules each of which consists essentially of a plurality of hydroxy-terminated polyethylene oxide chains attached to a divinyl benzene core, to a reagent to affix reagent groups to the hydroxy termini, said reagent groups permitting subsequent attachment of amino or thiol groups to the PEO chain ends by displacement, thereby forming activated polyethylene oxide star molecules with active reagent end groups; b) separating the activated polyethylene oxide star molecules with active reagent end groups from the organic solvent; c) dissolving the activated polyethylene oxide star molecules in an aqueous solution; and d) contacting the solution of step (c) with a support surface containing amino and/or thiol groups to covalently bind the reagent terminated star molecules, thereby immobilizing the reagent terminated star molecules in a dense layer to the support surface.
Claim 3
Dependent Claim 25 words
The method of claim 1, wherein the support surface is selected from the group consisting of particles, porous polymeric membranes, polymeric film, and biomedical devices.
Claim 4
Dependent Claim 42 words
The method of claim 1, wherein the support surface is selected from the group consisting of blood contacting vascular prostheses, angioplastic stents, cardiovascular suture, metabolic support catheters, angioplastic balloon catheters, artificial hearts, ventricular assist devices, hemodialysis membranes and membranes for extracorporeal oxygenators.
Claim 5
Dependent Claim 34 words
The method of claim 1, wherein the reagent is selected from the group consisting of tresyl chloride, tosyl chloride, mesyl chloride, epichlorhydrin, cyanuric chloride, carbonyl diimidazole and a mixture of succinic anhydride and succinimide.
Claim 6
Dependent Claim 9 words
A product produced by the method of claim 1.
Claim 7
Dependent Claim 61 words
The method of claim 1, further comprising the steps of: e) washing the support surface to remove any non-bound star molecules, leaving the activated polyethylene oxide star molecules remaining bound thereto; and f) contacting the support surface after step (e) with an affinity ligand having amino and/or thiol groups thereon, to covalently bind the ligand to the activated polyethylene oxide chains.
Claim 8
Dependent Claim 27 words
The method of claim 6, wherein the affinity ligand is selected from the group consisting of antibodies, Protein A, F ab fragments of antibodies and active polysaccharides.
Claim 9
Dependent Claim 11 words
The method of claim 7, wherein the active polysaccharide is heparin.
Claim 10
Independent Claim 95 words
A method of separating and purifying a ligate, comprising the steps of: a) providing a support surface having coated thereon, a layer comprising polyethylene oxide star molecules having a plurality of ligand-terminated polyethylene oxide chains attached to a divinyl benzene core; b) contacting a sample containing a ligate under conditions sufficient to bind the ligate to the ligand; c) removing any unbound ligates from the PEO star layer surface; d) adjusting ionic strength and/or pH of the sample to thereby remove the bound ligate from the PEO star layer; and e) collecting the bound ligates.
Claim 11
Independent Claim 95 words
A method of separating and purifying a ligate, comprising the steps of: a) providing a support surface having coated thereon, a layer comprising polyethylene oxide star molecules having a plurality of ligand-terminated polyethylene oxide chains attached to a divinyl benzene core; b) contacting a sample containing a ligate under conditions sufficient to bind the ligate to the ligand; c) removing any unbound ligates from the PEO star layer surface; d) adjusting ionic strength and/or pH of the sample to thereby remove the bound ligate from the PEO star layer; and e) collecting the bound ligates.
Claim 12
Dependent Claim 30 words
The method of claim 9, wherein the support surface is selected from the group consisting of silica particles, porous polymeric material, polymeric film and ultrahigh molecular weight high density polyethylene.
Claim 13
Dependent Claim 22 words
The method of claim 10, wherein the ligate is selected from the group consisting of macromolecules, monoclonal antibodies, antigens, viruses and cells.
Claim 14
Dependent Claim 23 words
The method of claim 11, wherein the cells are selected from the group consisting of blood platelets, white blood cells and endothelial cells.
Claim 15
Dependent Claim 26 words
The method of claim 9, wherein the ligand is selected from the group consisting of antibodies, Protein A, F ab fragments of antibodies, and active polysaccharides.
Claim 16
Dependent Claim 11 words
The method of claim 13, wherein the active polysaccharide is heparin.
Claim 17
Dependent Claim 18 words
The method of claim 13, wherein the ligand is a monoclonal anti-Protein C IgG or Fab fragment thereof.
Claim 18
Dependent Claim 22 words
A biocompatible, non-thrombogenic layer, comprising immobilized polyethylene star molecules having a plurality of hydroxy-terminated polyethylene oxide chains attached to a polymeric core.
Claim 19
Dependent Claim 22 words
A biocompatible, non-thrombogenic layer, comprising immobilized polyethylene star molecules having a plurality of hydroxy-terminated polyethylene oxide chains attached to a polymeric core.
Claim 20
Dependent Claim 49 words
The layer of claim 16, wherein the star molecules comprise from about six to about two hundred hydroxy-terminated polyethylene oxide chains attached to a polymeric core that is divinyl benzene, wherein each chain has a molecular weight range of from about 1,000 to about 10,000 atomic mass units (a.m.u.).
Claim 21
Dependent Claim 28 words
A contact lens having a covalently linked surface layer of immobilized polyethylene oxide star molecules having a plurality of hydroxy-terminated polyethylene oxide chains attached to a polymeric core.
Claim 22
Dependent Claim 28 words
A contact lens having a covalently linked surface layer of immobilized polyethylene oxide star molecules having a plurality of hydroxy-terminated polyethylene oxide chains attached to a polymeric core.
Claim 23
Dependent Claim 35 words
A contact lens of claim 18, wherein the polymeric core of the PEO star molecule is divinyl benzene and each chain of the star molecule has a molecular weight from about 1,000 to about 10,000.
Claim 24
Dependent Claim 10 words
A contact lens made by the method of claim 1.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-01-03 1997-07-05 1998-01-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-01-03 2001-07-05 2002-01-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-01-03 2005-07-05 2006-01-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag